Efficacy of Once-Daily Ophthalmic Bilastine for the Treatment of Allergic Conjunctivitis: A Dose-Finding Study.

Gomes, P J; Ciolino, J B; Arranz, P; Hernández, G; Fernández, N

Gomes, P J; Ciolino, J B; Arranz, P; Hernández, G; Fernández, N.

Afiliación

Gomes PJ; Ora, Inc., Andover, Massachusetts, USA.
Ciolino JB; Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts, USA.
Arranz P; Department of Research, Development, and Innovation, FAES FARMA, Bizkaia, Spain.
Hernández G; Department of Research, Development, and Innovation, FAES FARMA, Bizkaia, Spain.
Fernández N; Department of Research, Development, and Innovation, FAES FARMA, Bizkaia, Spain.

J Investig Allergol Clin Immunol ; 33(4): 271-280, 2023 Jul 27.

Article en En | MEDLINE | ID: mdl-35234641

Asunto(s)

Antialérgicos; Conjuntivitis Alérgica; Adulto; Humanos; Conjuntivitis Alérgica/tratamiento farmacológico; Piperidinas/efectos adversos; Bencimidazoles/efectos adversos; Prurito; Soluciones Oftálmicas; Método Doble Ciego; Antialérgicos/efectos adversos

Palabras clave

Allergic conjunctivitis; Antihistamine; Bilastine; Ocular itching; Once-daily; Preservative-free

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Conjuntivitis Alérgica / Antialérgicos Tipo de estudio: Diagnostic_studies Idioma: En Revista: J Investig Allergol Clin Immunol Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2023 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google